OpenAI Enters the AI-Bio Arms Race with GPT-Rosalind
OpenAI has officially unveiled GPT-Rosalind — its first frontier reasoning model purpose-built for biology, drug discovery, and translational medicine. Named after the British chemist Rosalind...
Selected coverage the editors think is worth your time, drawn from across the site.
72 articles
OpenAI has officially unveiled GPT-Rosalind — its first frontier reasoning model purpose-built for biology, drug discovery, and translational medicine. Named after the British chemist Rosalind...
For more than a decade, Oxford Nanopore Technologies was effectively alone in the commercial nanopore DNA sequencing, a market that it created. All that changed...
Drug discovery has two big machine learning stories: The first — de novo design, where AI conjures entirely new protein binders from scratch — has...
Amazon Web Services (AWS) today introduced BioDiscovery, a platform designed to unify biological data processing, AI model development, and scalable experimentation workflows within a single...
Sixteen years ago today on April 14, 2003, one of the most ambitious scientific endeavors in history reached its defining milestone. The Human Genome Project—a...
A new pipeline marries de novo protein design with robotic sample prep and NMR spectroscopy — producing atomic-resolution data at a pace that was unthinkable...
If you thought your not so comfortable wet lab jobs were safe, think again. The launch of the Cloud Lab platform by Ginkgo Bioworks represents...
This open-source project gives AI coding assistants superpowers for scientific research — from drug discovery to genomic analysis.